Search Awardees

Haima Therapeutics LogoHaima Therapeutics

UEI: JKZPL4NA9V21 • CAGE: 7P1L6

Overview

Awardee Type
Parent
Federal Capability Statement
Research, development, and commercialization of therapeutic to mitigate bleeding inn non-compressible hemorrhage and other bleeding complications.
Keywords
Therapeutics, Hemorrhage control, Synthetic Platelets, Nanotechnology, liposomes
Headquarters
Cleveland, OH
United States
Federal contract and grant recipient HAIMA THERAPEUTICS LLC (UEI JKZPL4NA9V21, CAGE 7P1L6) is headquartered in Cleveland OH. Its primary registered NAICS is 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology). The partnership was founded in June 2016 and federally registered in June 2016.

Federal Award Analysis

Haima Therapeutics federal award history

$-

Contracts

$-

Subcontracts

$-

Grants

$-

Subgrants

$-

Total

Interactive Stacked Bar Chart


No Results
Calculating
Calculating


No Results
Calculating
Calculating


No Results
Calculating
Calculating
Year Contracts Subcontracts Grants Subgrants


No Results
Calculating
Calculating


No Results
Calculating
Calculating


No Results
Calculating
Calculating


No Results
Calculating
Calculating


No Results
Calculating
Calculating

Federal Registration and Certifications

Legal Name
HAIMA THERAPEUTICS LLC
UEI
JKZPL4NA9V21
CAGE Code
7P1L6
SBA Certifications
None
Self Certifications
Woman Owned Business
Woman Owned Small Business
Entity Structure
Partnership or Limited Liability Partnership

People

Vendor contacts at Haima Therapeutics

Subscribe to find 500K+ key government decision markers

Free Trial Schedule Demo

Contract Vehicles

Haima Therapeutics multi-award contract vehicles

IDV Awards

Haima Therapeutics indefinite delivery vehicle awards

Contract Awards

Haima Therapeutics prime contract awards

Grant Awards

Haima Therapeutics direct grants

Subgrant Awards

Haima Therapeutics subgrant awards

Teaming Partners

Disclosed awardee sub and prime contract and grant relationships

Haima Therapeutics